Yüklüyor......

Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma

[Image: see text] Multiple myeloma remains an incurable malignancy of plasma cells. Novel therapies, notably proteasome inhibitors and immunomodulatory drugs, have improved the survival of multiple myeloma patients; however, patients either present with, or develop resistance to, these therapies. Re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ACS Pharmacol Transl Sci
Asıl Yazarlar: Mynott, Rachel L., Wallington-Beddoe, Craig T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Chemical Society 2021
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204322/
https://ncbi.nlm.nih.gov/pubmed/34151200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.1c00074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!